What Is PrEP and Why Should You Use It?

Pre-exposure prophylaxis (PrEP) is an innovative medical advancement in HIV prevention that significantly reduces the risk of transmission. Designed for individuals at higher risk, PrEP is available in two forms: daily or bi-monthly. Both options are highly effective when used correctly and provide a proactive approach to protecting your health.

How Does PrEP Work?

PrEP contains antiretroviral medications, the same type used to treat HIV, but in individuals who are HIV-negative, these drugs act as a protective barrier against infection. When taken as prescribed, PrEP prevents the virus from establishing an infection in the body, offering up to 99% effectiveness in preventing HIV transmission through sexual contact and up to 74% effectiveness for individuals who inject drugs.

PrEP Works Best When Taken Consistently

Daily PrEP (Truvada, Descovy): Requires taking one pill per day for continuous protection.
Bi-Monthly PrEP (Apretude): Administered as a shot every two months, eliminating the need for daily medication.

The choice depends on individual lifestyle, medical history, and adherence preferences.

Who Should Consider Taking PrEP?

PrEP is recommended for individuals at higher risk of HIV exposure, including:

Sexually Active Individuals - Those with multiple partners or partners whose HIV status is unknown.
LGBTQ+ Community - Particularly gay, bisexual, and transgender individuals who may be at increased risk.
Serodiscordant Couples - Individuals with an HIV-positive partner who is not yet virally suppressed.
People Who Inject Drugs - Those who share needles or equipment.
Sex Workers - Individuals who may have limited control over protection methods.

If you are unsure whether PrEP is right for you, a quick risk assessment with one of our providers can help determine your eligibility.

Daily vs. Bi-Monthly PrEP: Choosing the Right Option

Daily PrEP (Truvada, Descovy)

Taken once daily for full protection.
Requires consistent adherence for effectiveness.
Suitable for most individuals, including men and women.
Descovy is not recommended for people assigned female at birth who engage in vaginal sex.

Bi-Monthly PrEP (Apretude)

Administered as a bi-monthly shot (every 8 weeks).
Provides continuous protection without the need for daily medication.
Ideal for those who struggle with daily pill adherence.
Requires an in-clinic visit for each injection.

Both options provide highly effective HIV prevention, and the best choice depends on personal preference and healthcare provider recommendations.